Treatment of E. coli Urinary Tract Infection
Based on the susceptibility testing results, trimethoprim/sulfamethoxazole (TMP-SMX) is the most appropriate first-line antibiotic for this E. coli urinary tract infection.
Interpretation of Urinalysis and Culture Results
The urinalysis shows clear evidence of a urinary tract infection:
- Cloudy urine appearance
- Positive nitrite test
- 2+ leukocyte esterase
- 6-10 WBCs/hpf
- Many bacteria
The culture confirms Escherichia coli (>100,000 CFU/mL) as the causative organism, which is consistent with the most common pathogen in UTIs. E. coli causes 75-95% of uncomplicated UTIs 1.
Antibiotic Selection Algorithm
First-line options (based on susceptibility testing):
Trimethoprim/Sulfamethoxazole (TMP-SMX): Susceptible
- Dosing: 160/800 mg (one double-strength tablet) twice daily for 3-5 days
- Advantages: Inexpensive, good tissue penetration, oral administration
Nitrofurantoin: Susceptible
- Dosing: 100 mg twice daily for 5 days
- Advantages: Low resistance rates, concentrates in urine
- Limitations: Not for pyelonephritis, avoid if GFR <30 mL/min
Ciprofloxacin: Susceptible
Alternative options (based on susceptibility testing):
- Cephalosporins (cefazolin, cefpodoxime, ceftriaxone): All susceptible
- Amoxicillin/clavulanate: Susceptible
- Gentamicin: Susceptible (can be used for UTI as monotherapy) 4
Recommended Treatment Plan
First choice: TMP-SMX 160/800 mg twice daily for 3-5 days
- Rationale: Effective against susceptible E. coli, inexpensive, good tissue penetration, recommended by guidelines 1
- Duration: 3 days for uncomplicated cystitis; 7-14 days if complicated or upper tract involvement
Alternative if TMP-SMX contraindicated (allergy, pregnancy, etc.):
- Nitrofurantoin 100 mg twice daily for 5 days (if no signs of pyelonephritis and normal renal function)
- Cephalexin 500 mg four times daily for 5-7 days
For severe infection or pyelonephritis:
- Ciprofloxacin 500 mg twice daily for 7-14 days 2
- Consider initial IV therapy with ceftriaxone 1-2 g daily if hospitalization required
Special Considerations
Resistance patterns: Despite the organism being susceptible to ampicillin in this case, resistance to ampicillin is common (37.7% in North America) 5, making it a less reliable empiric choice.
Fluoroquinolone use: Despite susceptibility, fluoroquinolones (ciprofloxacin, levofloxacin) should be reserved for more severe infections due to increasing resistance rates and risk of adverse effects 3.
Duration of therapy:
- Uncomplicated cystitis: 3-5 days
- Complicated UTI: 7-14 days
- Pyelonephritis: 7-14 days 1
Follow-up: Routine follow-up urine cultures are not recommended for uncomplicated UTIs that resolve clinically.
Common Pitfalls to Avoid
Treating asymptomatic bacteriuria: Only treat if symptomatic or in specific populations (pregnancy, pre-urologic procedures).
Overuse of broad-spectrum antibiotics: Use the narrowest effective antibiotic based on susceptibility testing.
Inadequate duration: Too short a course may lead to treatment failure; too long contributes to resistance.
Ignoring susceptibility results: Always check susceptibility patterns before prescribing, especially in recurrent UTIs.
Failure to consider anatomical abnormalities: In recurrent or complicated UTIs, consider imaging to rule out structural abnormalities.